ATOS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ATOSAtossa Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ATOSAtossa Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ATOS 1

NDAQNasdaqsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customerSource: SEC EDGAR

25 more · LLY chain ›

ATOSAtossa Therapeutics, Inc.

2.01▼−0.62%· post 2.13· delayed

Mkt cap$21.2MRevenue—Revenue—

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,354.07· delayed

After hoursNov 6 '26delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 6 '26delayed

ATOSAtossa Therapeutics, Inc.

LLYELI Lilly & Co

2.01▼−0.62%post 2.13delayed

Price

1,360.90▼−0.28%post 1,354.07delayed

$21.2M

Mkt cap

$1.2T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

ATOS2.01▼−0.62%vsLLY1,360.90▼−0.28%After hoursNov 6 '26delayed